A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients
- Status
- RECRUITING
- Phase
- NA
GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Status
- RECRUITING
- Phase
- PHASE1
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2